Clinical Trials Logo
  1. Home
  2. Sepsis
  3. NCT06063707
  4. Details
NCT06063707 Clinical Trial

The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDS

Sepsis Clinical Trial

Official title:
The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDS

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06063707
Other study ID # 2022ZDSYLL402-P01
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date October 1, 2023
Est. completion date September 1, 2024

Study information
Verified date October 2023
Source Southeast University, China
Contact Jingyuan Xu, M.D.
Phone 008613851417209
Email 13851417209@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To observe the changes of plasma rTEM levels in patients with sepsis, sepsis induced ARDS, and to explore its clinical significance.

Description:

90 patients will be included in this study. Blood samples from these patients in the first day, the third day, were maintained and tested to detect the change of rTEM level. Severity of illness and survival status of every patient were recorded within 28 days. The objective is to observe the changes of plasma rTEM levels in patients with sepsis, sepsis induced ARDS, and to explore its clinical significance.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 90
Est. completion date September 1, 2024
Est. primary completion date August 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Diagnosed as Sepsis 3.0 Patients signing informed consent Exclusion Criteria: Pregnant women Patients with tumor?hepatitis?liver cirrhosis?acute myocardial infarction?chronic renal tubular nephritis?interstitial pneumonia?acute pancreatitis?systemic lupus erythenatosus?ulcerative colitis?crohn's disease?HELLP syndrome

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Taking peripheral blood
Taking peripheral blood of no more than 3ml

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Southeast University, China

Outcome
Type Measure Description Time frame Safety issue
Primary Mortality 28day mortality 28 day
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Recruiting NCT05578196 - Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections. N/A
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3